Skip to main content
BHVN logo

Biohaven Ltd.

BHVNNYSEHealthcareBiotechnology

$14.45Today:- (-)1Y −9.88%

As of Oct 26, 2026 close

Market cap
$2.18B
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$7.48$18.57
Volume (live)
-
Avg. volume (3M)
3.38M

Biohaven (BHVN) Income Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), Biohaven posted a net loss of $738.82M, compared with a net loss of $846.42M a year earlier.

Biohaven Income Statement Analysis

Values in millions USD

Scroll to see more
Biohaven Ltd. income statement - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2017
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2017
Revenue & Gross Profit
Revenue0.000.000.000.000.000.000.000.00
Cost of Revenue4.140.000.000.000.000.000.000.00
Gross Profit-4.140.000.000.000.000.000.000.00
Operating Expenses
Research & Development598.05795.87373.28437.07181.4998.46344.670.00
Selling, General & Administrative110.3189.2462.77130.8637.4116.05134.450.00
Operating Expenses745.38885.11436.05567.93218.90114.51479.120.00
Operating Income-745.38-885.11-436.05-567.93-218.90-114.51-479.120.00
Other Income/Expense
Interest Income14.5921.3317.730.000.000.000.000.00
Interest Expense0.000.000.000.000.000.00-12.710.00
Other Income/Expense16.0039.4253.00-1.916.47-4.16-49.260.00
Income
Income Before Tax-737.38-845.69-409.55-569.84-212.43-118.67-528.390.00
Income Tax Expense1.440.74-1.380.441.370.000.420.00
Net Income-738.82-846.42-408.17-570.28-213.80-118.67-528.810.00
Net Income - Continuous Operations-738.82-846.42-408.17-570.28-213.80-118.67-528.810.00
Net Income - Discontinued Operations--------
EBITDA-698.45-837.83-429.14-568.46-217.51-114.43-479.120.00
EBIT-708.37-885.11-436.05-567.93-218.90-114.51--
Depreciation & Amortization9.927.866.911.391.390.070.170.05
Earnings Per Share
Basic EPS-7.00-9.00-6.00-13.00-6.00-3.00-11.00-
Diluted EPS-7.00-9.00-6.00-13.00-6.00-3.00-11.00-
Basic Shares Outstanding107.6291.2371.2044.7435.8239.3848.490.00
Diluted Shares Outstanding107.6291.2371.2044.7435.8239.3848.490.00

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Biohaven Financial Statements

Is Biohaven profitable?

No. Biohaven reported a net loss of $738.82M in fiscal 2025. In fiscal 2024 it lost $846.42M.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition